Extrapulmonary small cell carcinoma: A clinicopathological study with identification of potential diagnostic mimics

Histopathology

Volumn 61, Issue 3, 2012, Pages 454-464

  Quinn, Anne Marie ^a   Blackhall, Fiona ^b   Wilson, Godfrey ^a   Danson, Sarah ^c   Clamp, Andrew ^b   Ashcroft, Linda ^b   Brierley, Judith ^a   Hasleton, Philip ^d  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c WESTON PARK HOSPITAL   (United Kingdom)

^d HEBREW UNIVERSITY   (Israel)

Author keywords

34 E12; Extrapulmonary small cell carcinoma; Small cell carcinoma; Synaptophysin; TTF 1

Indexed keywords

EOSIN; HEMATOXYLIN; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; EXTRAPULMONARY SMALL CELL CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL; UTERINE CERVIX;

ADOLESCENT; ADULT; AGED; CARCINOMA, SMALL CELL; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84865373832     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04247.x     Document Type: Article

References (46)

1. Frazier SR, Kaplan PA, Loy TS. The pathology of extrapulmonary small cell carcinoma. Semin. Oncol. 2007; 34; 30-38.
2. Haider K, Shahid RK, Finch D et al. Extrapulmonary small cell cancer: a Canadian province's experience. Cancer 2006; 107; 2262-2269.
3. Travis WD. The concept of pulmonary neuroendocrine tumours. In Travis WD, Brambilla E, Muller-Hermelink HK et al. eds. Pathology and genetics of tumours of the lung, pleura, thymus and heart (IARC WHO classification of tumours). Lyon, France: IARC Press, 2004; 19-34.
4. Richardson RL, Weiland LH. Undifferentiated small cell carcinoma in extrapulmonary sites. Semin. Oncol. 1982; 9; 484-496.
5. Cicin I, Karagol H, Uzunoglu S et al. Extrapulmonary small cell carcinoma compared with small cell lung carcinoma. Cancer 2007; 110; 1068-1076.
6. Brennan SM, Gregory DL, Stillie A et al. Should extrapulmonary small cell cancer be managed like small cell lung cancer? Cancer 2010; 116; 888-895.
7. Walenkamp AME, Sonke GS, Sleijfer DT. Clinical and therapeutic aspects of extrapulmonary small cell carcinoma. Cancer Treat. Rev. 2009; 35; 228-236.
8. Demellawy DE, Khalifa MA, Ismiil N et al. Primary colorectal small cell carcinoma: a clinicopathological and immunohistochemical study of 10 cases. Diagn. Pathol. 2007; 2.
9. Yun J-P, Zhang MF, Hou J-H et al. Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases. BMC Cancer 2007; 7.
10. Brenner B, Tang LH, Klimstra DS et al. Small cell carcinomas of the gastrointestinal tract: a review. J. Clin. Oncol. 2004; 22; 2730-2739.
11. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother. Rep. 1973; 4; 31-42.
12. Van Der Gaast A, Verwey J, Prins E et al. Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas. Cancer 1990; 65; 422-424.
13. den Bakker MA, Willemsen S, Grünberg K et al. Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability. Histopathology 2010; 56; 356-363.
14. Tan D, Zander DS. Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update. Int. J. Clin. Exp. Pathol. 2008; 1; 19-31.
15. Travis WD, Brambilla E, Noguchi M et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International multidisciplinary classification of lung adenocarcinoma. J. Thorac. Oncol. 2011; 6; 244-285.
16. Mukesh M, Cook N, Hollingdale AE et al. Small cell carcinoma of the urinary bladder: a 15-year retrospective review of treatment and survival in the Anglian Cancer Network. BJU Int. 2009; 103; 747-752.
17. Gersell DJ, Mazoujian G, Mutch DG et al. Small cell undifferentiated carcinoma of the cervix. A clinicopathologic, ultrastructural, and immunocytochemical study of 15 cases. Am. J. Surg. Pathol. 1988; 12; 684-698.
18. Johnson TL, Zarbo RJ, Lloyd RV et al. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing. Mod. Pathol. 1988; 1; 216-223.
19. Achilles E, Padberg BC, Holl K et al. Immunocytochemistry of paragangliomas - value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis. Histopathology 1991; 18; 453-458.
20. Kliewer KE, Wen DR, Cancilla PA et al. Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques. Hum. Pathol. 1989; 20; 29-39.
21. Williams GT. Endocrine tumours of the gastrointestinal tract - selected topics. Histopathology 2007; 50; 30-41.
22. Albores-Saavedra J, Latif S, Carrick KS et al. CD56 reactivity in small cell carcinoma of the uterine cervix. Int. J. Gynecol. Pathol. 2005; 24; 113-117.
23. Tajima S, Maeda I, Kanemaki Y et al. Evaluation of CD56 and CD57 immunostainings for discrimination between endocrine ductal carcinoma in situ and intraductal papilloma. Pathol. Int. 2010; 60; 459-465.
24. Kaufmann O, Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 2000; 36; 415-420.
25. Jagirdar J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch. Pathol. Lab. Med. 2008; 132; 384-396.
26. Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am. J. Surg. Pathol. 2000; 24; 1217-1223.
27. McCluggage WG, Sargent A, Bailey A et al. Large cell neuroendocrine carcinoma of the uterine cervix exhibiting TTF1 immunoreactivity. Histopathology 2007; 51; 405-407.
28. McCluggage WG, Kennedy K, Busam KJ. An immunohistochemical study of cervical neuroendocrine carcinomas: neoplasms that are commonly TTF1 positive and which may express CK20 and P63. Am. J. Surg. Pathol. 2010; 34; 525-532.
29. Yao JL, Madeb R, Bourne P et al. Small cell carcinoma of the prostate: an immunohistochemical study. Am. J. Surg. Pathol. 2006; 30; 705-712.
30. Matoso A, Singh K, Jacob R et al. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors. Appl. Immunohistochem. Mol. Morphol. 2010; 18; 142-149.
31. Graham AD, Williams AR, Salter DM. TTF-1 expression in primary ovarian epithelial neoplasia. Histopathology 2006; 48; 764-765.
32. Siami K, McCluggage WG, Ordonez NG et al. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas. Am. J. Surg. Pathol. 2007; 31; 1759-1763.
33. Rekhtman N. Neuroendocrine tumors of the lung: an update. Arch. Pathol. Lab. Med. 2010; 134; 1628-1638.
34. Viberti L, Bongiovanni M, Bussolati G. 34betaE12 cytokeratin immunodetection in the differential diagnosis of small cell tumors of lung. Int. J. Surg. Pathol. 2000; 8.
35. Lyda MH, Weiss LM. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. Hum. Pathol. 2000; 31; 980-987.
36. Howe MC, Chapman A, Kerr K et al. Neuroendocrine differentiation in non small cell lung cancerand its relation to prognosis and therapy. Histopathology 2005; 46; 195-201.
37. di Sant'Agnese PA. Neuroendocrine differentiation in human prostatic carcinoma. Hum. Pathol. 1992; 23; 287-296.
38. Wang W, Epstein JI. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. Am. J. Surg. Pathol. 2008; 32; 65-71.
39. Li AF, Li AC, Hsu CY et al. Small cell carcinomas in gastrointestinal tract: immunohistochemical and clinicopathological features. J. Clin. Pathol. 2010; 63; 620-625.
40. Nicholson SA, Beasley MB, Brambilla E et al. Small cell lung carcinoma (SCLC). A clinicopathologic study of 100 cases with surgical specimens. Am. J. Surg. Pathol. 2002; 26; 1184-1197.
41. Lee SS, Lee JL, Ryu MH et al. Extrapulmonary small cell carcinoma: single center experience with 61 patients. Acta Oncol. 2007; 46; 846-851.
42. Cheng L, Jones TD, McCarthy RP et al. Molecular evidence for a commom clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am. J. Pathol. 2005; 166; 1533-1539.
43. Rossi G, Bertolini F, Sartori G et al. Primary mixed adenocarcinoma and small cell carcinoma of the appendix: a clinicopathologic, immunohistochemical, and molecular study of a hitherto unreported tumor. Am. J. Surg. Pathol. 2004; 28; 1233-1239.
44. Hoang MP, Maitra A, Gazdar AF et al. Primary mammary small cell carcinoma: a molecular analysis of 2 cases. Hum. Pathol. 2001; 32; 753-757.
45. Klimstra DS, Modlin IR, Adsay NV et al. Pathology reporting of neuroendocrine tumors: application of the delphic consensus process to the development of a minimum pathology data set. Am. J. Surg. Pathol. 2010; 34; 300-313.
46. Paner GP, McKenney JK, Epstein JI et al. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma. Am. J. Surg. Pathol. 2008; 32; 1022-1028.